Insider Transactions

What MapLight Therapeutics Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

	3 months	12 months
Open-market buys	6	12
Sells	45	138
Total trades	64	191

Shares traded

	3 months	12 months
Acquired	0	0
Disposed	0	0
Net activity	+0	+0

Common stock only — 191 reported trades in the last 12 months are in a security these totals do not cover.

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

All Buys Sells

Insider	Relation	Date	Transaction	Shares	Price	Value	Shares held
Lillie James Woodruff	Chief Scientific Officer	Aug 17	Grant / award · A	+7,730	—	—	210,110
Kreitzer Anatol	Chief Discovery Officer	Aug 17	Grant / award · A	+6,020	—	—	180,926
Foff Erin Pennock	Chief Medical Officer	Aug 17	Grant / award · A	+13,360	—	—	312,261
Gillis Jonathan	CAO and Interim CFO	Aug 17	Grant / award · A	+2,222	—	—	152,482
Gillis Jonathan	CAO and Interim CFO	Aug 17	Grant / award · A	+6,020	—	—	150,260
Kroeger Christopher A.	Chief Executive Officer	Aug 17	Grant / award · A	+23,145	—	—	1,269,600
Hanson Kristopher	General Counsel	Aug 17	Grant / award · A	+7,730	—	—	153,553
Catalyst4, Inc.	10% owner	Aug 14	Open-market buy · P	+4,400,000	$11.38	+$50.1M	25,306,689
Lillie James Woodruff	Chief Scientific Officer	Aug 03	Open-market sale · S	−22,082	$12.54	−$277K	202,380
Catalyst4, Inc.	10% owner	Jul 30	Open-market buy · P	+1,000,000	$13.00	+$13M	20,906,689
Catalyst4, Inc.	10% owner	Jul 29	Open-market buy · P	+3,000	$12.63	+$37.9K	19,906,689
Cox Troy	Director	Jul 28	Open-market buy · P	+15,620	$9.52	+$149K	15,620
Catalyst4, Inc.	10% owner	Jul 28	Open-market buy · P	+65,137	$11.69	+$761K	19,903,689
Catalyst4, Inc.	10% owner	Jul 28	Open-market buy · P	+141,088	$10.74	+$1.52M	19,838,552
Kroeger Christopher A.	Chief Executive Officer	Jul 17	Sale for tax withholding · S	−16,779	$37.90	−$636K	1,246,455
Lillie James Woodruff	Chief Scientific Officer	Jul 17	Sale for tax withholding · S	−2,077	$37.90	−$78.7K	224,462
Hanson Kristopher	General Counsel	Jul 17	Sale for tax withholding · S	−1,130	$37.90	−$42.8K	145,823
Foff Erin Pennock	Chief Medical Officer	Jul 17	Sale for tax withholding · S	−3,656	$37.90	−$139K	298,901
Gillis Jonathan	CAO and Interim CFO	Jul 17	Disclosed 10b5-1 sale · S	−900	$38.17	−$34.4K	144,240
Gillis Jonathan	CAO and Interim CFO	Jul 17	Disclosed 10b5-1 sale · S	−16,969	$37.61	−$638K	145,140

Page 1 of 10 · showing the 20 most recent Sign up free to view all 191 transactions and filter by insider →